Hypercoagulability Inhibits Monocyte Transendothelial Migration Through Protease-Activated Receptor-1-, Phospholipase-Cβ-, Phosphoinositide 3-Kinase-, and Nitric Oxide-Dependent Signaling in Monocytes and Promotes Plaque Stability
Author(s) -
Stefanie Seehaus,
Khurrum Shahzad,
Muhammed Kashif,
Ilya A. Vinnikov,
Martin Schiller,
Hongjie Wang,
Thati Madhusudhan,
Volker Eckstein,
Angelika Bierhaus,
Florian Bea,
Erwin Blessing,
Hartmut Weiler,
David Frommhold,
Peter P. Nawroth,
Berend Isermann
Publication year - 2009
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.109.849539
Subject(s) - thrombin , medicine , monocyte , nitric oxide , tissue factor , phospholipase a2 , phospholipase c , thrombomodulin , microbiology and biotechnology , inflammation , receptor , immunology , biology , coagulation , platelet , biochemistry , enzyme
Clinical studies failed to provide clear evidence for a proatherogenic role of hypercoagulability. This is in contrast to the well-established detrimental role of hypercoagulability and thrombin during acute atherosclerotic complications. These seemingly opposing data suggest that hypercoagulability might exert both proatherogenic and antiatherogenic effects. We therefore investigated whether hypercoagulability mediates a beneficial effect during de novo atherogenesis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom